Informations générales (source: ClinicalTrials.gov)
French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer
Observational
Hôpital NOVO (Voir sur ClinicalTrials)
janvier 2026
juin 2027
26 janvier 2026
This study aims to validate a French version of the Nasal Reconstruction FACE-Q
questionnaire for patients who have undergone nasal reconstruction or prosthetic
rehabilitation after surgery for nasal skin cancer. The questionnaire evaluates
appearance, quality of life, and possible side effects related to the reconstruction.
We hypothesize that the validated French version will provide a reliable and standardized
tool to assess patient satisfaction and health-related quality of life in this context.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Nadia BENMOUSSA-REBIBO | 23/07/2026 07:45:06 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Bichat | Caroline HALIMI LEVY, Doctor | Contact (sur clinicalTrials) | |||
| HOPITAL NOVO | Khaled AL TABAA, Doctor | Contact (sur clinicalTrials) | |||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHU Toulouse - 31400 - Toulouse 2972315 - France | Guillaume DE BONNECAZE, Pr | Contact (sur clinicalTrials) | |||
| HNIA Toulon - 83000 - Toulon 2972328 - France | Jean-Baptiste MORVAN, Pr | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Antoine Lacassagne - 06000 - Nice 2990440 - France | Gilles POISSONNET, Doctor | Contact (sur clinicalTrials) | |||
| Centre Antoine Lacassagne - 06000 - Nice 2990440 - France | Gilles POISSONNET, Doctor | Contact (sur clinicalTrials) | |||
| CHU Caen - 14000 - Caen 3029241 - France | Maxime HUMBERT, Dr | Contact (sur clinicalTrials) | |||
| CHU Caen - 14000 - Caen 3029241 - France | Maxime HUMBERT, Dr | Contact (sur clinicalTrials) | |||
| Hôpital Lariboisière (AP-HP) - 75010 - Paris 2988507 - France | Benjamin VERILLAUD, Pr | Contact (sur clinicalTrials) | |||
| Institut Curie - 75005 - Paris 2988507 - France | Maria LESNIK, Doctor | Contact (sur clinicalTrials) | |||
| Institut Curie - 75005 - Paris 2988507 - France | Maria LESNIK, Doctor | Contact (sur clinicalTrials) | |||
Critères
Tous
PATIENTS Age ≥ 18 years Patient who has undergone excision of a cutaneous, mucocutaneous,
or vestibular nasal cancer with surgical reconstruction using a flap or prosthetic
rehabilitation, performed more than 4 months ago, with stable results, and less than 3
years ago Patient informed of the study and not opposed to participation
CONTROL Age ≥ 65 years Subject informed and not opposed to participating in the study
Subject who has never undergone facial trauma or surgery, and without major comorbidity,
defined as follows:
- No heart failure (moderate or severe heart failure, history of heart attack within
the last 6 months);
- No severe chronic respiratory disease (no stage III-IV COPD, no prolonged oxygen
therapy);
- No uncontrolled diabetes or associated severe complications;
- No active immunosuppressive diseases or high-dose immunosuppressive treatment;
- No unstable or severe facial dermatological conditions;
- No comorbidities seriously affecting quality of life or respiratory function (at the
investigator's discretion).
Translated with DeepL.com (free version)
Exclusion Criteria:
PATIENTS
- Patient under anticoagulant or antiplatelet therapy
- Non-French-speaking patient
- Patient under legal protection (e.g., guardianship, legal safeguard) or with limited
legal capacity
- Patient unlikely to cooperate with the study and/or poor anticipated compliance as
judged by the investigator (including psychiatric disorders other than depressive
disorder or cognitive impairment)
- Pregnant or breastfeeding woman
CONTROL
- Non-English speaking subject
- Subject under guardianship or legal protection, legally incompetent or with limited
legal capacity
- Subject unlikely to cooperate in the study and/or anticipated low cooperation by the
investigator (particularly those with psychiatric disorders other than depression or
cognitive disorders)
- Pregnant or breastfeeding women